Mitochondrial remodeling in differentiating neuroblasts.
Mitochondria are able to change their shape through fission and fusion events, leading to a continuous remodeling of the mitochondrial network. Whereas the mitochondrial fission has been extensively studied and primarily related to the onset and progression of apoptosis, the physiological function of the opposite process of fusion is far less understood. With this study we analyzed the process of mitochondrial fusion in immortalized hippocampal neuroblasts searching for a relationship with specific changes in cellular physiology. The mitochondrial dynamics was examined in every stage of the cell cycle and a link was found between the enhancement of the mitochondrial transmembrane potential DeltaPsi(m), the widespread mitochondrial fusion and the process of neurite outgrowth. An identical mitochondrial reorganization also appeared in response to the pro-differentiating agent retinoic acid. The single-cell analysis in time-lapse of the mitochondrial response to RA evidenced a free calcium raise in the mitochondrial matrix coupled with the DeltaPsi(m) increase and it confirmed the close coordination between these two events and the fusion of mitochondria. The modulation of oxidative phosphorylation by carbonyl cyanide m-chlorophenyl hydrazone (CCCP) or pyruvate, underscored the importance of DeltaPsi(m) changes both in shaping the mitochondrial network and in regulating the rate of neurite outgrowth. We also report that the mitochondrial fusion observed during neurite outgrowth is not a consequence of the microtubule reorganization, since pharmacological treatments capable of blocking the microtubule dynamics failed to inhibit the mitochondrial remodeling in response to RA.
Voccoli
Vladimir
V
Istituto di Neuroscienze CNR, Via G. Moruzzi 1, 56100 Pisa, Italy.
Colombaioni
Laura
L
D000818:Animals; D002118:Calcium / Q000378:metabolism; D002258:Carbonyl Cyanide m-Chlorophenyl Hydrazone / Q000494:pharmacology; D002453:Cell Cycle; D002454:Cell Differentiation / Q000187:drug effects; D002460:Cell Line; D006624:Hippocampus / Q000166:cytology* / Q000502:physiology; D053078:Membrane Potential, Mitochondrial; D051379:Mice; D008870:Microtubules / Q000187:drug effects / Q000502:physiology; D008928:Mitochondria / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D016501:Neurites / Q000187:drug effects / Q000502:physiology; D009474:Neurons / Q000166:cytology* / Q000502:physiology / Q000648:ultrastructure; D015739:Nocodazole / Q000494:pharmacology; D010085:Oxidative Phosphorylation / Q000187:drug effects; D017239:Paclitaxel / Q000494:pharmacology; D019289:Pyruvic Acid / Q000494:pharmacology; D013234:Stem Cells / Q000166:cytology* / Q000502:physiology / Q000648:ultrastructure; D014212:Tretinoin / Q000494:pharmacology
D002258:Carbonyl Cyanide m-Chlorophenyl Hydrazone; D014212:Tretinoin; D019289:Pyruvic Acid; D017239:Paclitaxel; D015739:Nocodazole; D002118:Calcium